Analyst Expectations for Surgery Partners's Future
Portfolio Pulse from Benzinga Insights
In the last quarter, Surgery Partners (NASDAQ:SGRY) received 4 bullish analyst ratings. The company has an average 12-month price target of $48.25, with a high of $50.00 and a low of $45.00. This average price target has increased by 7.22% over the past month.
July 31, 2023 | 4:01 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Surgery Partners received 4 bullish analyst ratings in the last quarter, with an average 12-month price target of $48.25, which has increased by 7.22% over the past month.
The bullish analyst ratings and the increase in the average price target over the past month indicate a positive outlook for Surgery Partners. This could potentially lead to an increase in the company's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100